Start date: 2020-01-01End date: 2024-12-31
Budget: 8.000.000 €
Centre bugdet: 579.000 €
Funding: Programa H2020: 579.000 €
The main aim of this project is to make a qualitative leap in the treatment of infarcted heart diseases. The majority of treatments of chronic infarcted hearts are pharmaceutical and include the use of ventricular assist devices (VADs) that consist of a mechanical pump that supports heart function and blood flow.
This project will seek to generate customised biological tissue using 3D printing technologies (bioprinting and electrospinning), making it possible to generate a construct with optimal replication of the mechanical properties of the native myocardium and which is capable of delivering signals for alignment with the cardiac cells that will populate it. These cells will not only provide the ability to contract, they will also form a functional vascular network.
Leartiker has performed the following activities: